COVID-19 Testing
Our comprehensive patient-centric solution
includes two tests
Our viral RT-PCR test and antibody test were authorized under FDA (EUA) on March 31st, 2020
Our viral RT-PCR RNA test was authorized under FDA (EUA) in late March and is 99.9% accurate. Our Viral RT-PCR RNA test is used as the first diagnostic method to determine if an active COVID-19 infectious is present in the patient
Antibody testing, also known as serology testing, detects signs of a past SARS-CoV-2 infection. It evaluates if a patient has had previous exposure to the virus, developing the antibodies for COVID-19
A COVID-19 test detects an active SARS-CoV-2 virus. An antibody test detects if an individual has had the virus in the past.
There is currently not enough evidence to support the idea that having antibodies guarantees a patient is protected against reinfection with COVID-19.
Combining viral RT-PCR RNA tests and antibody tests allows patients to identify both if they are currently infected with COVID-19, and if they may have previously been infected.
With this information, patients have a better understanding of their health history. Meanwhile, employers are able to understand who is currently infected, who has been infected and who has not been. Based on that data, they’re able to make informed decisions about safe societal re-entry.
